# FDA recall D-0651-2017

> **West-Ward Columbus, Inc.** · Class III · drug recall initiated 2017-04-04.

## Product

Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ --  NDC 0054-0338-19

## Reason for recall

Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

## Distribution

The recalled product was distributed to the following state: OH.  There are no Canada accounts for this recall.  There are no Mexico accounts for this recall.  There are no government accounts for this recall.

## Key facts

- **Recall number:** D-0651-2017
- **Recalling firm:** West-Ward Columbus, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-04-04
- **Report date:** 2017-04-19
- **Termination date:** 2018-09-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0651-2017

## Citation

> AI Analytics. FDA recall D-0651-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0651-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
